Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia

NCT01960387 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped lack of accrual

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Clofarabine
DRUG: Cytarabine

Sponsor

University of Pittsburgh